News-Medical.net Angiotensin-receptor blockers including telmisartan, valsartan, candesartan , irbesartan and losartan, are generally used interchangeably to control bl...
CMAJ Background: Telmisartan , unlike other angiotensin-receptor blockers, is a partial agonist of peroxisome proliferator–activated receptor-γ, a property that has bee...
PR Newswire (press release) On June 27, 2013, Forest Laboratories Inc. (Forest) reported positive top line results from its eight-week pivotal Phase III clinical trial, conducted to evaluate the efficacy and safety of investigational fixed dose combination (FDC) of nebivolol and ...
NASDAQ Forest Laboratories, Inc. ( FRX ) recently presented positive topline data on its hypertension drug, Bystolic (nebivolol) when used in combination with valsartan . The 8-week randomized, double-blind, placebo-controlled phase III study was conducted to ... and more »
